SMS Pharmaceuticals schedules 38th AGM for September 29 via video conference
- SMS Pharmaceuticals schedules its 38th AGM for September 29, 2026
- The meeting will be held via video conferencing without physical presence
- Remote e-voting runs from September 25 to September 28, 2026
- Record date for dividend eligibility is fixed at September 22, 2026
- Book closure period extends from September 23 to September 29, 2026

*this image is generated using AI for illustrative purposes only.
SMS Pharmaceuticals has scheduled its 38th Annual General Meeting for Tuesday, September 29, 2026. The event will be conducted through Video Conferencing or Other Audio Visual Means, adhering to Ministry of Corporate Affairs and SEBI guidelines.
The meeting is set to begin at 10:30 am. Shareholders will transact ordinary and special business, including the approval of financial statements for the fiscal year ended March 31, 2026.
Voting and Record Dates
Remote e-voting facilities will be available from Friday, September 25, 2026, at 9:00 am until Monday, September 28, 2026, at 5:00 pm. Central Depository Services Limited (CDSL) has been appointed as the agency to facilitate electronic voting.
| Key Date | Detail |
|---|---|
| AGM Date | September 29, 2026 |
| E-voting Start | September 25, 2026 |
| E-voting End | September 28, 2026 |
| Record Date | September 22, 2026 |
| Book Closure | September 23-29, 2026 |
Only members whose names appear in the Register of Members as of the cut-off date, September 22, 2026, are eligible to vote. The Register of Members and Share Transfer Books will remain closed from September 23 to September 29, 2026, inclusive.
Dividend Eligibility
The company has fixed September 22, 2026, as the record date for determining eligibility for dividends on equity shares, subject to approval at the AGM. Shareholders are advised to update their KYC and bank account details with their Depository Participants to ensure direct receipt of dividends.
Historical Stock Returns for SMS Pharmaceuticals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.90% | +8.29% | +7.96% | +5.95% | +67.86% | +130.00% |
What specific financial performance metrics or strategic initiatives will be highlighted in the FY2026 results presented at the AGM?
How might the proposed dividend payout ratio impact SMS Pharmaceuticals' future capital allocation and R&D investment plans?
Are there any special resolutions regarding executive compensation, board restructuring, or new share issuances scheduled for shareholder approval?


































